55 Participants NeededMy employer runs this trial

Microvideos for HPV Vaccination

EW
Overseen ByEcho Warner, MPH, PhD, SB
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Utah
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how microvideos can improve HPV vaccination rates among young adults who survived childhood cancer. The researchers aim to understand how factors like travel, money, and knowledge influence treatment choices for rural cancer patients in Utah. Participants will watch short, engaging videos about HPV vaccines on social media. Ideal candidates for this trial are cancer survivors aged 18-26 who use Facebook and haven't completed all their HPV vaccine doses.

As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance HPV vaccination strategies and support cancer survivors in rural areas.

What prior data suggests that microvideos for HPV vaccination education are safe?

Research has shown that educational videos about the HPV vaccine, like those used in this study, are generally safe and easy to understand. These videos help people learn about the HPV vaccine and feel more positive about it. The vaccine itself is known to be very safe. A review of 25 studies found no credible evidence of any serious side effects from the vaccine. Thus, using short and informative videos is a safe way to help people understand and accept the HPV vaccine.12345

Why are researchers excited about this trial?

Researchers are excited about the use of microvideos for HPV vaccination education because they offer a fresh approach to engaging and educating unvaccinated emerging adult survivors of childhood cancer. Unlike traditional methods such as pamphlets or lengthy seminars, these microvideos are short, under two minutes, and designed to deliver key information in a captivating and concise manner. By leveraging social media for distribution, the approach meets young adults where they are most active, potentially increasing vaccination uptake in a demographic that might not respond to conventional educational methods.

What evidence suggests that microvideos are effective for HPV vaccination education?

Research has shown that videos can effectively encourage people to receive the HPV vaccine. For example, one study found that vaccination rates increased from 17.8% to 63.6% within a year after just one video session. Another study revealed that 76% of parents who watched the videos supported HPV vaccination, compared to 61% who did not. These video interventions have been particularly successful among young people, including college students, by boosting both their intention to get vaccinated and the actual number who do. In this trial, participants will receive HPV vaccination education through short, engaging microvideos. These microvideos have proven to be a powerful way to persuade people to get vaccinated, making them a promising tool for increasing HPV vaccine coverage.12678

Who Is on the Research Team?

EW

Echo Warner, MPH, PhD, SB

Principal Investigator

Huntsman Cancer Institute

Are You a Good Fit for This Trial?

This trial is for cancer survivors aged 18-26 who were diagnosed with childhood cancer in the past ten years, use or are willing to use Facebook, and have not finished all recommended HPV vaccine doses. Participants must speak English and cannot already be fully vaccinated for HPV.

Inclusion Criteria

I use Facebook or am willing to create an account for the study.
I am 18-26 and was diagnosed with childhood cancer in the last 10 years.
I have not finished all recommended doses of the HPV vaccine.

Exclusion Criteria

Unable to speak and understand English
I have not received the full HPV vaccine series.
Participants who take part in the Aim 1 focus groups are ineligible for the Aim 2 social media group

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive HPV vaccine education through microvideos as part of a pilot quasi-experimental social media intervention

4 weeks
Virtual engagement through social media

Follow-up

Participants are monitored for feasibility, acceptability, and satisfaction of the microvideo education

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Microvideos: HPV Vaccination Education

Trial Overview

The study tests whether short educational videos about the HPV vaccine shared on Facebook can help increase vaccination rates among young adult cancer survivors. The research uses surveys and interviews to understand decision-making around vaccination.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: HPV Vaccination EducationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials
1,169
Recruited
1,623,000+

Prevent Cancer Foundation

Collaborator

Trials
7
Recruited
1,500+

Huntsman Cancer Institute

Collaborator

Trials
14
Recruited
7,700+

Citations

Video-based interventions to promote HPV vaccination among ...

Evidence indicates that video-based interventions are effective in promoting vaccination intentions and uptake among youth, including college students.

HPV Vaccine Education for Medical Assistants: Impact Study

With only one HCP training, HPV vaccination rates improved from 17.8% to 63.6% in 1 year. Additionally, in the same study, 80% of the surveyed parents reported ...

Interventions to Improve HPV Vaccine Coverage

Additionally, a higher percentage of parents of girls in the intervention group (76%) were supportive of HPV vaccination compared to the control group (61%) [11] ...

Review Effective strategies in human papillomavirus (HPV) ...

This scoping review searched six databases for intervention studies which measured the uptake of HPV vaccination of rural, low SES, ethnic minority, ...

How Can HPV Vaccination Rates be Improved? - PolicyLab

Only 35% of adolescent girls are fully vaccinated against HPV, compared to 70-80% for other common adolescent vaccines. PolicyLab developed a three-part ...

HPV Vaccine Safety and Effectiveness Data

Learn about the scientific data showing HPV vaccine effectiveness and safety ... No data indicate that the protection from HPV vaccination lessens over time.

Human Papillomavirus (HPV) - VEC Vaccine Notes

addresses common questions and discusses the relative risks and benefits of the disease and vaccine. Watch the episode to find out: Number of ...

HPV Videos Education & Promotion Project

This video provides up-to-date information about the burden of HPV-related disease, and vaccine safety information.